Generic drug sales increased 20 percent and sales of the anesthetic Lidoderm increased 16 percent. Stocks ended at $1.27 per share, above expectations of $1.18 per share.
Lower expectations were due in part to two patent lawsuit settlements.
More Articles on Anesthesia:
First Grad Completes TeamHealth Anesthesia Management Fellowship
Colorado Court Says CRNAs Can Administer Anesthesia
Somnia Releases White Paper on Anesthesia’s Role in Perioperative Management
Next Up in Financial Management
-
The Pennsylvania Department of Health revoked Sharon (Pa.) Regional Medical Center’s license, effective Nov. 17, and ordered the hospital to…
-
Health systems across the country are making very different bets on whether to be in the insurance business. Carle Health,…
-
Port Angeles, Wash.-based Olympic Medical Center is considering converting to a smaller critical access hospital, according to a report from…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
